Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: Assessment of myocardial wall motion and perfusion

Journal of the American College of Cardiology

Volumn 56, Issue 15, 2010, Pages 1225-1234

  Korosoglou, Grigorios ^a   Elhmidi, Yacine ^a   Steen, Henning ^a   Schellberg, Dieter ^a   Riedle, Nina ^a   Ahrens, Johannes ^a   Lehrke, Stephanie ^a   Merten, Constanze ^a   Lossnitzer, Dirk ^a   Radeleff, Jannis ^a   Zugck, Christian ^a   Giannitsis, Evangelos ^a   Katus, Hugo A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

combined assessment; coronary artery disease; highdose dobutamine stress testing; inducible ischemia; myocardial perfusion; wall motion

Indexed keywords

ATROPINE; DIURETIC AGENT; DOBUTAMINE;

AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DIAGNOSTIC VALUE; DRUG DOSE INCREASE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE REVASCULARIZATION; HEART PERFUSION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC USE; DOSE RESPONSE; DRUG EFFECTS; EXERCISE TEST; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; PATHOPHYSIOLOGY; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CORONARY ARTERY DISEASE; DOBUTAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 77957605139     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.06.020     Document Type: Article

References (27)

1. R. Gebker, C. Jahnke, and R. Manka Additional value of myocardial perfusion imaging during dobutamine stress magnetic resonance for the assessment of coronary artery disease Circ Cardiovasc Imaging 1 2008 122 130
2. W.E. Boden, R.A. O'Rourke, and K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
3. D.B. Pryor, L. Shaw, and C.B. McCants Value of the history and physical in identifying patients at increased risk for coronary artery disease Ann Intern Med 118 1993 81 90
4. W.B. Meijboom, C.A. van Mieghem, and N.R. Mollet 64-slice computed tomography coronary angiography in patients with high, intermediate, or low pretest probability of significant coronary artery disease J Am Coll Cardiol 50 2007 1469 1475
5. A. Hakeem, S. Bhatti, and K.S. Dillie Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death Circulation 118 2008 2540 2549
6. A.S. Levey, J. Coresh, and T. Greene Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254
7. M.D. Cerqueira, N.J. Weissman, and V. Dilsizian Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 2002 539 542
8. G. Korosoglou, A.E. Dubart, and K.G. DaSilva Jr. Real-time myocardial perfusion imaging for pharmacologic stress testing: added value to single photon emission computed tomography Am Heart J 151 2006 131 138
9. T.A. Kaandorp, J.J. Bax, and J.D. Schuijf Head-to-head comparison between contrast-enhanced magnetic resonance imaging and dobutamine magnetic resonance imaging in men with ischemic cardiomyopathy Am J Cardiol 93 2004 1461 1464
10. G. Korosoglou, K.G. da Silva Jr., and N. Labadze Real-time myocardial contrast echocardiography for pharmacologic stress testing: is quantitative estimation of myocardial blood flow reserve necessary? J Am Soc Echocardiogr 17 2004 1 9
11. C. Jahnke, E. Nagel, and R. Gebker Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging Circulation 115 2007 1769 1776
12. V. Bodi, J. Sanchis, and M.P. Lopez-Lereu Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease J Am Coll Cardiol 50 2007 1174 1179
13. J. Krivokapich, J.S. Child, R.S. Gerber, V. Lem, and D. Moser Prognostic usefulness of positive or negative exercise stress echocardiography for predicting coronary events in ensuing twelve months Am J Cardiol 71 1993 646 651
14. M.L. Geleijnse, A. Elhendy, and R.T. van Domburg Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain J Am Coll Cardiol 28 1996 447 454 (Pubitemid 26274342)
15. S.C. Smart, T. Knickelbine, F. Malik, and K.B. Sagar Dobutamine-atropine stress echocardiography for the detection of coronary artery disease in patients with left ventricular hypertrophy Importance of chamber size and systolic wall stress Circulation 101 2000 258 263
16. R. Hoffmann, H. Lethen, and T. Marwick Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms J Am Coll Cardiol 27 1996 330 336
17. L.J. Shaw, D.S. Berman, and D.J. Maron Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Circulation 117 2008 1283 1291
18. E. Dall'Armellina, T.M. Morgan, and S. Mandapaka Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index J Am Coll Cardiol 52 2008 279 286
19. A. Wahl, I. Paetsch, and A. Gollesch Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases Eur Heart J 25 2004 1230 1236
20. D. Poldermans, P.M. Fioretti, and E. Boersma Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: a single-center experience Circulation 99 1999 757 762
21. M.L. Geleijnse, P.M. Fioretti, and J.R. Roelandt Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography J Am Coll Cardiol 30 1997 595 606
22. C. Bjork Ingul, E. Rozis, S.A. Slordahl, and T.H. Marwick Incremental value of strain rate imaging to wall motion analysis for prediction of outcome in patients undergoing dobutamine stress echocardiography Circulation 115 2007 1252 1259
23. G. Korosoglou, S. Lehrke, and A. Wochele Strain-encoded CMR for the detection of inducible ischemia during intermediate stress J Am Coll Cardiol Img 3 2010 361 371
24. P. Verdecchia, G. Schillaci, and C. Borgioni Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass J Am Coll Cardiol 25 1995 871 878
25. R.B. Devereux, K. Wachtell, and E. Gerdts Prognostic significance of left ventricular mass change during treatment of hypertension JAMA 292 2004 2350 2356
26. R.Y. Kwong, A.K. Chan, and K.A. Brown Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease Circulation 113 2006 2733 2743
27. K. Steel, R. Broderick, and V. Gandla Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease Circulation 120 2009 1390 1400